Description
1,Glycemic control: GLP‑1 receptor agonist to boost insulin secretion and suppress glucagon for blood glucose regulation.
2,Satiety enhancement: delays gastric emptying, increases fullness and supports weight management research.
3,Cardiovascular protection: studied to reduce risks of major adverse cardiovascular events in diabetic models.
4,Long‑acting property: resistant to DPP‑4 degradation, showing extended half‑life for once‑weekly profile.
